WO2000076966A3 - Derives d'indolinylamide - Google Patents

Derives d'indolinylamide Download PDF

Info

Publication number
WO2000076966A3
WO2000076966A3 PCT/EP2000/005114 EP0005114W WO0076966A3 WO 2000076966 A3 WO2000076966 A3 WO 2000076966A3 EP 0005114 W EP0005114 W EP 0005114W WO 0076966 A3 WO0076966 A3 WO 0076966A3
Authority
WO
WIPO (PCT)
Prior art keywords
indolinylamide
derivatives
antiviral drugs
compounds
antiviral
Prior art date
Application number
PCT/EP2000/005114
Other languages
German (de)
English (en)
Other versions
WO2000076966A2 (fr
Inventor
Gabriele Handke
Judith Baumeister
Wolfgang Bender
Ulrich Betz
Michael Brands
Peter Eckenberg
Ruediger Fischer
Martin Hendrix
Kerstin Henninger
Axel Jensen
Joerg Keldenich
Gerald Kleymann
Jutta Maessen
Udo Schneider
Olaf Weber
Original Assignee
Bayer Ag
Gabriele Handke
Judith Baumeister
Wolfgang Bender
Ulrich Betz
Michael Brands
Peter Eckenberg
Ruediger Fischer
Martin Hendrix
Kerstin Henninger
Axel Jensen
Joerg Keldenich
Gerald Kleymann
Jutta Maessen
Udo Schneider
Olaf Weber
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag, Gabriele Handke, Judith Baumeister, Wolfgang Bender, Ulrich Betz, Michael Brands, Peter Eckenberg, Ruediger Fischer, Martin Hendrix, Kerstin Henninger, Axel Jensen, Joerg Keldenich, Gerald Kleymann, Jutta Maessen, Udo Schneider, Olaf Weber filed Critical Bayer Ag
Priority to AU62623/00A priority Critical patent/AU6262300A/en
Publication of WO2000076966A2 publication Critical patent/WO2000076966A2/fr
Publication of WO2000076966A3 publication Critical patent/WO2000076966A3/fr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/08Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne de nouveaux composés, un procédé pour leur préparation, ainsi que leur utilisation comme médicament, notamment comme médicament antiviral.
PCT/EP2000/005114 1999-06-16 2000-06-05 Derives d'indolinylamide WO2000076966A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU62623/00A AU6262300A (en) 1999-06-16 2000-06-05 Indolinylamide derivatives

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19927415A DE19927415A1 (de) 1999-06-16 1999-06-16 Indolinylharnstoffderivate
DE19927415.0 1999-06-16

Publications (2)

Publication Number Publication Date
WO2000076966A2 WO2000076966A2 (fr) 2000-12-21
WO2000076966A3 true WO2000076966A3 (fr) 2001-07-19

Family

ID=7911403

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2000/005114 WO2000076966A2 (fr) 1999-06-16 2000-06-05 Derives d'indolinylamide

Country Status (3)

Country Link
AU (1) AU6262300A (fr)
DE (1) DE19927415A1 (fr)
WO (1) WO2000076966A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2001256733A1 (en) * 2000-05-16 2001-11-26 Takeda Chemical Industries Ltd. Melanin-concentrating hormone antagonist
MA41140A (fr) 2014-12-12 2017-10-17 Cancer Research Tech Ltd Dérivés de 2,4-dioxo-quinazoline-6-sulfonamide en tant qu'inhibiteurs de la parg
MA41179A (fr) 2014-12-19 2017-10-24 Cancer Research Tech Ltd Composés inhibiteurs de parg
CA3018026A1 (fr) 2016-04-06 2017-10-12 Innovative Molecules Gmbh Derives d'aminothiazole utiles en tant qu'agents antiviraux
MA50609B1 (fr) 2017-10-05 2023-03-31 Innovative Molecules Gmbh Énantiomères de thiazoles substitués utilisés comme composés antiviraux

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024343A1 (fr) * 1995-12-29 1997-07-10 Boehringer Ingelheim Pharmaceuticals, Inc. Derives de phenylthiazole dotes de proprietes anti virus de l'herpes

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997024343A1 (fr) * 1995-12-29 1997-07-10 Boehringer Ingelheim Pharmaceuticals, Inc. Derives de phenylthiazole dotes de proprietes anti virus de l'herpes

Also Published As

Publication number Publication date
DE19927415A1 (de) 2000-12-21
AU6262300A (en) 2001-01-02
WO2000076966A2 (fr) 2000-12-21

Similar Documents

Publication Publication Date Title
MY134892A (en) Substituted 2-thio-3,5-dicyano-4-phenyl-6-aminopyridines and their use
MXPA03010201A (es) Derivados de 2-piridin-ciclohexan-1,4-diamina sustituidos.
AU2003282094A1 (en) Novel dihydroxy-methylphenyl derivatives, method for the production and use thereof as medicaments
HK1065027A1 (en) Carboxamide-substituted phenylurea derivatives andmethod for production thereof as medicaments
WO2001010816A3 (fr) Derives de 2-dialkylaminoalkylbiphenyle
MY134880A (en) Thiazolyl amide derivatives
WO2003014079A8 (fr) Polymorphe stable de flibanserine, procede de preparation associe et utilisation dudit polymorphe dans la preparation de medicaments
AU3364101A (en) Substituted piperazine derivatives, production thereof and use thereof as medicaments
WO2001047928A3 (fr) Nouveaux imidazo[1,3,5]triazinones et leur utilisation
AU2002238855A1 (en) N-phenylarylsulfonamide compound, drug containing the compound as active ingredient, intermediate for the compound, and processes for producing the same
WO2001027110A3 (fr) Derives d'imidazo-3-yl-amine bicycliques substitues sur le sixieme chainon
WO2002030870A3 (fr) Derives de c-cyclohexylmethylamine substitues
WO2002010152A3 (fr) Nouveaux derives d'indol et leur utilisation comme medicaments
HUP0204360A3 (en) Substituted norbornylamino derivatives, method for the production thereof, use thereof as a medicament and medicaments containing said compounds
WO2001002350A3 (fr) Nouveaux aminosulfonamides et amidosulfonamides utilises en tant qu'agents antiviraux
WO2004106307A3 (fr) Nouveaux derives d’imidazoles, leur preparation et leur utilisation en tant que medicament
EP1076057A4 (fr) Febrifugine et isofebrifugine, et leurs procedes de preparation
WO2001049654A3 (fr) Derives d'aminomethyle-phenyle-cyclohexane substitues
HUP0600084A2 (en) Pharmaceutical compositions containing ascorbic acid derivatives, methods of production of the active ingredient
WO2003089449A3 (fr) Composes aminoalkylsteroles avec activite anti-tumeur et neuroprotective
AU7904600A (en) Substituted piperazine derivatives, the production and use thereof as medicaments
WO2000076966A3 (fr) Derives d'indolinylamide
WO2001049651A3 (fr) Derives d'aminomethyle-phenyle-cyclohexane
WO2004043900A3 (fr) Derives de 4-alkyl-/4-alcenyl-/4-alcynylmethyl-/1-aryl-cyclohexylamine
AU2003252467A1 (en) Process for preparation of 1,3-benzodioxole-2-spiro- cycloalkane derivatives

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP